Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neuroblastoma 2Meningeal Carcinomatosis 2Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Medulloblastoma 1Desmoplastic Small Round Cell Tumor 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Thiotepa 2Melphalan 2Doxorubicin 2thymoglobulin 1sodium thiosulfate 1omburtamab I-131 1fludarabine phosphate 1X-Rays 1Trabectedin 1Tacrolimus 1Stem Cell Transplantation 1Specimen Handling 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cytoreduction Surgical Procedures 1Cyclosporins 1Cyclosporine 1Cisplatin 1Busulfan 1Bone Marrow Transplantation 1Antilymphocyte Serum 1Amifostine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Desmoplastic Small Round Cell Tumor × omburtamab I-131 × Clear all
NCT00089245 2023-12-26

Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer

Y-mAbs Therapeutics

Phase 1 Terminated
177 enrolled
CNSSarcoma

Brain Neoplasms, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Meningeal Carcinomatosis, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡